Condition
Paclitaxel-Induced Peripheral Neuropathy
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 2 (1)
Trial Status
Not Yet Recruiting3
Recruiting2
Clinical Trials (5)
Showing 5 of 5 trials
NCT07572461Not ApplicableNot Yet Recruiting
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based Chemotherapy
NCT07504770Not ApplicableNot Yet RecruitingPrimary
Surgical Glove Compression to Prevent Paclitaxel Neuropathy
NCT06964802Not ApplicableRecruiting
The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy
NCT07410169Phase 2Not Yet Recruiting
Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy
NCT06763575Not ApplicableRecruitingPrimary
Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy
Showing all 5 trials